Similar articles

• Prevalence and risk factors of suppurative complications in children with pneumonia.

  François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. François P, et al. Acta Paediatr. 2010 Jun;99(6):861-6. doi: 10.1111/j.1651-2227.2010.01734.x. Epub 2010 Feb 19. Acta Paediatr. 2010. PMID: 20178517
• Development of parapneumonic empyema in children.

  Lahti E, Peltola V, Virkki R, Alanen M, Ruuskanen O. Lahti E, et al. Acta Paediatr. 2007 Nov;96(11):1686-92. doi: 10.1111/j.1651-2227.2007.00511.x. Epub 2007 Sep 19. Acta Paediatr. 2007. PMID: 17888048
• Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.

  Li ST, Tancredi DJ. Li ST, et al. Pediatrics. 2010 Jan;125(1):26-33. doi: 10.1542/peds.2009-0184. Epub 2009 Nov 30. Pediatrics. 2010. PMID: 19948570
• Respiratory infections: pneumonia, lung abscess, and empyema.

  Puligandla PS, Laberge JM. Puligandla PS, et al. Semin Pediatr Surg. 2008 Feb;17(1):42-52. doi: 10.1053/j.sempedsurg.2007.10.007. Semin Pediatr Surg. 2008. PMID: 18158141 Review.
• [Anti-inflammatory drugs and community-acquired pneumonia].

  Dirou S, Voiriot G. Dirou S, et al. Rev Mal Respir. 2015 Oct;32(8):841-4. doi: 10.1016/j.rmr.2015.06.001. Epub 2015 Sep 12. Rev Mal Respir. 2015. PMID: 26372616 Review. French.